Blood centres that fail quality checks may face testing curbs
A failed quality check could stop a blood centre from carrying out routine testing. That matters because testing errors can put patients at risk, including by allowing unsafe or mismatched blood to be transfused. The proposal aims to make external quality checks a legal requirement rather than a voluntary exercise. Under the proposed mechanism, a centre that misses the required proficiency standard in a testing cycle cannot continue routine testing without review. It must investigate the cause of the failure and take corrective steps before normal testing can resume. State drugs controllers would receive audit reports directly and could use them in regulatory reviews. The recommendations have been submitted to the Drugs Consultative Committee, which is expected to make a final decision. The proposed consequences for non-compliant facilities include statutory fines, suspension of testing privileges, and disciplinary action by state regulators. These measures are proposals, not rules already in force. The National Blood Transfusion Council is expected to prepare transition arrangements and operational guidance before any amendments are notified.
What testing restrictions could blood centres face if they fail the proposed quality checks?
A failed quality check could stop a blood centre from carrying out routine testing. That matters because testing errors can put patients at risk, including by allowing unsafe or mismatched blood to be transfused. The proposal aims to make external quality checks a legal requirement rather than a voluntary exercise.
Under the proposed mechanism, a centre that misses the required proficiency standard in a testing cycle cannot continue routine testing without review. It must investigate the cause of the failure and take corrective steps before normal testing can resume. State drugs controllers would receive audit reports directly and could use them in regulatory reviews.
The recommendations have been submitted to the Drugs Consultative Committee, which is expected to make a final decision. The proposed consequences for non-compliant facilities include statutory fines, suspension of testing privileges, and disciplinary action by state regulators. These measures are proposals, not rules already in force. The National Blood Transfusion Council is expected to prepare transition arrangements and operational guidance before any amendments are notified.
What is an External Quality Assessment Scheme, and how do blind proficiency samples test a blood centre’s accuracy?
An External Quality Assessment Scheme, or EQAS, is an independent check of a blood centre’s testing performance. It helps reveal whether the centre’s procedures produce reliable results, rather than relying only on the centre’s own internal checks. The proposal would make participation mandatory for registered centres.
A reference centre sends proficiency samples that are blind: the receiving centre does not know the expected results. The centre tests them and reports its findings, which can then be compared with the reference results. The proposed samples cover blood grouping, cross-matching, haemoglobin, HIV, hepatitis B and C, syphilis, and malaria. Centres would test them the day after receiving them.
The proposal calls for periodic testing within a January-to-December calendar. Five national centres would distribute the samples, while state drugs controllers would receive audit reports directly. EQAS participation is currently voluntary in India, according to the article. The World Health Organization recommends compulsory participation as part of national haemovigilance and transfusion safety systems.
How many blood centres could be covered, and how much blood did India collect in 2024–25?
Roughly 5,000 registered blood centres across India could be covered by the proposed mandatory external quality checks. The proposal comes amid growing demand for dependable oversight of blood collection and testing. It would bring centres into a structured proficiency-testing system under the Drugs Rules, 1945, if approved.
India collected 14.6 million units of blood in 2024–25, according to the Union health ministry’s statement to Parliament in August 2025. That was a 15% increase from the previous year. Around 70% of the supply came from voluntary, non-remunerated donors, making strong quality management at blood centres important.
At present, EQAS participation by licensed centres is voluntary, and shortcomings in testing or collection have no real legal consequences, the article reports. The proposal has been submitted to the Drugs Consultative Committee, which will make a final decision. If approved, the NBTC is expected to develop a phased transition plan and operational guidelines before amendments are notified.
What must a centre do after failing a proficiency test, and what penalties could follow?
A failed proficiency test would require more than simply repeating the test. Under the proposal, a centre that does not meet the required standard in a cycle cannot continue routine testing without review. It must identify what went wrong and address the underlying problem before returning to normal testing.
The prescribed response is a formal root cause analysis, or RCA, followed by a corrective and preventive action protocol, or CAPA. The RCA investigates why the error occurred; CAPA is intended to correct the problem and help prevent it from recurring. Audit reports would go directly to state drugs controllers, supporting regulatory reviews and enforcement.
The proposed punishments for non-compliant facilities include statutory fines, suspension of testing privileges, and disciplinary action by state regulators. These are recommendations, not penalties already in force. The sub-committee has submitted its proposals to the Drugs Consultative Committee, which is expected to make a final decision. The article says the NBTC would develop transition arrangements and operational guidance before amendments are notified.
Why can’t screening donated blood for infections alone guarantee a safe transfusion?
Screening donated blood for infections is only one part of transfusion safety. The article quotes a physician saying that quality control must cover the full process, from donor selection and collection through testing, storage, compatibility checks, and administration. A failure at any stage can undermine safety even when infection screening is performed.
The article describes reported cases involving infected or mismatched transfusions in children. In Jharkhand, five children with thalassemia, aged five to seven, allegedly contracted HIV after transfusions at Chaibasa Sadar Hospital. The proposed proficiency samples would test blood centres on several measures, including HIV screening, blood grouping, and cross-matching.
External assessments are intended to identify testing inaccuracies before they compromise patient safety. The physician also cited validated procedures, trained staff, proper documentation, and continuous monitoring as necessary safeguards. At present, EQAS participation is voluntary. The proposal would make it compulsory and add formal investigation and corrective action when centres fail, extending oversight beyond infection screening alone.
Which organisations would monitor the tests and use the audit results to enforce compliance?
The proposed system divides the work between specialist testing centres and regulators. Five apex national EQAS centres would distribute blind reference samples to blood centres. State drugs controllers would receive all audit reports directly, giving them information to check whether centres meet the required standards.
The five named distribution centres are Christian Medical College Vellore, Indian Red Cross Society Mumbai, Santokba Durlabhji Memorial Hospital Jaipur, Post Graduate Institute of Medical Education and Research Chandigarh, and Gauhati Medical College Guwahati. Blood centres would test samples covering blood grouping, cross-matching, haemoglobin, HIV, hepatitis B and C, syphilis, and malaria.
State regulators already scrutinise blood centres, but mandatory EQAS participation would also bring greater Central government monitoring, according to the proposal. The recommendations were prepared by a sub-committee constituted by the CDSCO and submitted to the Drugs Consultative Committee. That committee will make a final decision on the proposal. The NBTC is expected to prepare transition plans and operational guidelines before amendments are notified.
Why must donor and patient blood be tested for compatibility before a transfusion?
Compatibility testing helps determine whether donated blood is suitable for a particular recipient. In standard transfusion practice, this includes checking blood groups and cross-matching donor and patient samples. The article does not explain the biology behind these checks, but it identifies compatibility checks as a necessary part of transfusion safety.
The article reports cases involving mismatched blood transfusions in children and lists blood grouping and cross-matching among the tests in the proposed proficiency scheme. These checks assess whether a centre can perform important testing accurately. The samples would be blind, so centres would not know the expected results before testing them.
Compatibility is one part of a broader safety process. The physician quoted in the article says quality control is needed from donor selection and collection to testing, storage, compatibility checks, and administration. The proposed mandatory external assessments would help identify testing inaccuracies before they compromise patient safety. They remain proposals awaiting a decision by the Drugs Consultative Committee.
This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.
Read more in the JupiteX app
Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.
Or read more news on the web